Inactive Instrument

Calendar Tetraphase Pharmaceuticals, Inc.

Equities

US88165N2045

Chart calendar Tetraphase Pharmaceuticals, Inc.

d503cfe2c6dadfb3bb0b97e736.-Wqm6plG7UbFq-QAD5_3wusAp574tdjCu4Fqj537Li0.jymQqP8fjxaWxbV1XarAjcZylsSox5ag9uck6visFk_MBMqI4DK4Po7GtQ~417c3a10630745facd7659a822bd2deb

Upcoming events on Tetraphase Pharmaceuticals, Inc.

No events available

Past events on Tetraphase Pharmaceuticals, Inc.

08/06/2020 07:30 pm Extraordinary Shareholders Meeting
08/06/2020 Extraordinary Shareholders Meeting - M&A Vote
08/05/2020 01:45 am Q1 2020 Earnings Release
12/03/2020 05:00 pm FY 2019 Earnings Release
13/11/2019 03:00 am Q3 2019 Earnings Call
13/11/2019 02:31 am Q3 2019 Earnings Release
05/10/2019 09:45 pm Infectious Disease Society of America Infectious Disease Week Conference - Poster Number: 2132
05/10/2019 09:45 pm Infectious Disease Society of America Infectious Disease Week Conference - Poster Number: 2259
05/10/2019 09:45 pm Infectious Disease Society of America Infectious Disease Week Conference - Poster Number: 2264
03/10/2019 09:45 pm Infectious Disease Society of America Infectious Disease Week Conference - Poster Number: 728
03/10/2019 09:45 pm Infectious Disease Society of America Infectious Disease Week Conference - Poster Number: 710
03/10/2019 09:45 pm Infectious Disease Society of America Infectious Disease Week Conference - Poster Number: 688
03/10/2019 09:45 pm Infectious Disease Society of America Infectious Disease Week Conference - Poster Number: 644
25/09/2019 07:30 pm Extraordinary Shareholders Meeting
10/09/2019 12:05 am H.C. Wainwright Global Investor Conference
09/08/2019 02:00 am Interim 2019 Earnings Call
09/08/2019 01:31 am Interim 2019 Earnings Release
24/06/2019 04:00 am American Society for Microbiology Microbe Meeting - Session: S339
23/06/2019 11:00 pm American Society for Microbiology Microbe Meeting - Poster #CPHM-862
23/06/2019 11:00 pm American Society for Microbiology Microbe Meeting - Poster #CPHM-865
  1. Stock Market
  2. Equities
  3. Stock
  4. Calendar Tetraphase Pharmaceuticals, Inc.